Skip to main content
Fig. 1 | Antimicrobial Resistance & Infection Control

Fig. 1

From: Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

Fig. 1Fig. 1

Temporal trend in community-onset vs healthcare-onset/associated bacteriuria caused by antimicrobial resistant E. coli by semester, 2014–2020. Note: bar = number of bacteriuria episodes, line = percent resistance. a ESBL-producing. 1. Community-onset. 2. Healthcare-onset/associated. b Nitrofurantoin. 1. Community-onset. 2. Healthcare-onset/associated. c Trimethoprim/sulfamethoxazole. 1. Community-onset. 2. Healthcare-onset/associated. d Ciprofloxacin. 1. Community-onset. 2. Healthcare-onset/associated. e Any resistance. 1. Community-onset. 2. Healthcare-onset/associated. f Multidrug resistance. 1. Community-onset. 2. Healthcare-onset/associated

Back to article page